& ldquo; The export of Chinese raw materials will enter the second platform period，The demand space for the international market for low -end basic materials tends to be saturated，High value -added raw material drugs with policy quality as the connotation of the product increase。& rdquo; April 25，At the Materials Pharmaceutical Market Information Conference held at Wuhan Pharmaceutical Conference，Industry authoritative experts in the future trend of chemicals and drugs are so outlook。
 
According to the China Chemical Pharmaceutical Industry Association Data，Decreased by the needs of European and American countries、Some factors such as improvement of some imported national standards，The growth rate of import and export trade in the pharmaceutical industry fell largely，The cumulative import and export volume of the whole year is 81 billion US dollars，increased by 10.5%year -on -year，The growth rate decreased by 29 percentage points from the previous year。This is mainly due to the incremental increase in large varieties caused by overcapacity and external environment in China、Light varieties are caused by the continuous low price operation。
 
but，Domestic basic drug system、Environmental Policy、The continuous advancement My stake betting appof My stake betting appindustrial upgrading policies such as the quality of generic drug quality，It is expected to effectively boost the raw material and drug market。
 
steady growth
 
According to statistics from the China Chemical and Pharmaceutical Industry Association，The export amount of the 75 chemicals and preparations of the 75 chemicals and preparations that focused on in 2012 dropped by 4.1%，The increase in 2011 was 2%，decreased 6.1 percentage points; of which，60%of the varieties of 64 medicine varieties of chemical raw materials increase，increased by 7 percentage points over the third quarter; 42.7%of the average price of varieties rose to varying degrees，But the increase is narrowed。
 
Division of large categories，Only hormone and amino acids increase the average unit price。Vitamin rose in the first half of，Price decline sharply in the third quarter，Downs 8.2%in the whole year。The decline in the export price of the preparation has narrowed，Fall 10.2%of the whole year。
 
In the first three quarters of 2012，24 major types of chemical raw materials decreased by 2.4%year -on -year，Supply export volume increased by 2.5%year -on -year。Where，Affected by antibiotic grading management，Anti -infected variety production decreased by 10.9%year -on -year，Supply export volume increased by 5.3%year -on -year;、The output of large rings and amam alcohols increased year -on -year，9 small categories of exports increased year -on -year; the yield of relief thermal analgesics increased by 4.8%，Supply export increased by 15.4%; vitamin output decreased by 5.3%year -on -year，The supply export is basically the same，Among them, the output of vitamin C and its salt in the first three quarters of the first three quarters，decreased by 8.7%year -on -year，Supply export 62,000 tons，decreased by 2.6%year -on -year; Vitamin E production increased by 11.2%year -on -year in the first three quarters，Exit fell 5%; antibiotic intermediates have different performances，6-APA output increased by 17.2%，Exit 44%，Penicol industrial salt output decreased by 21.4%year -on -year，Exports increased by 9.2%year -on -year。
 
There are statistical data show，There are 31 My stake betting appvarieties stake sports betting appexported more than 100 million yuan in 2012，Two reductions compared to 2011，The top 3 in the top 3 are heparin sodium ($ 772 million)、Citric acid ($ 750 million) and vitamin E ($ 720 million)。There are 11 varieties that have decreased year -on -year export amount，Among them, thiocyanic acid, erythromycin decreased by 32.12%，Sodium sodium heparies drops 16.1%。
 
On the exit structure，Sweetter、Anti -virus drugs (anti -AIDS)、Cardiovascular medication、Fast、Hormonal raw materials gradually reveal strong，Anti -tumor raw medicine reaches 38.29 million US dollars，immunosuppressants and hypoglycemic drugs exceeded $ 1 million。
 
Generally speaking，2012 global economic situation is not optimistic，The domestic pharmaceutical and raw material market supply contradictions that are greater than seeking continues to exist，Drugs compete for prices in bidding，These negative factors make the growth rate of the export of raw materials in 2012。
 
Shen Xianji, deputy director of the Expert Committee of the China Chemical Pharmaceutical Industry Association, said at the meeting，The current international economic recovery speed slows down，The downward pressure on the domestic economy still exists，In addition, all provinces are exploring the new mode of bidding for drugs，Add uncertain factors to operation，Enterprises need to pay close attention to related dynamics。

Follow the follow -up
 
Take a comprehensive，The overall phenomenon of large varieties presents incremental non -appreciation，Some hundreds of millions of dollars of varieties fell to the lowest level in history，Export growth point from the raw medicine to the preparation preparation of the raw material formula formula preparation preparation and the medicine。
 
Statistics display，The current decline in price mainly includes ordinary heparin、Vitamin E raw material、thiocyanic acid erythromycin, etc.，The variety running low in price is mainly 6APA、Amoxicin、Pingtache pain, etc.，The volume and price are reduced by vitamin C; the growth varieties are mainly small categories，Including Suspein、stake sports betting appOgimilain、stake online sports bettingHormonal and Coenzyme Q10; generic drugs and intermediates perform well，such as Satan category、​​Atropine、Lazazole and small varieties hair gum raw materials; direct particles and sterile powder -grade preparation raw materials，and the development momentum of the re -exports of joint ventures in China。
 
Chief researcher of Health Network Wu Huifang believes，Analysis from the recent policy factors that affect the price of raw drugs in the prices of the drug drug，The price market in my country is in the overall upward trend，It mainly includes three aspects:
 
First，The new version of GMP requires aseptic preparation to complete the certification by the end of 2013，It indicates that sterile raw materials must be verified first。and antibiotics are currently mainly sterile preparations，The first verified manufacturer means rising costs，But it also means that there is a right to speak in terms of price and market monopoly，Being able to put forward the price increase on the market，So the price of sterile raw materials will take this as a reason to rise，Ruhayao's ceptopylin、Amoxicin and other varieties are entering this process。
 
Second，Environmental protection problems in the production of raw and drugs have become fatal targets，In March of this March this March, the State Administration of Environmental Protection announced the key emission testing varieties and the list of enterprises，Environmental protection pressure requires companies to increase their strength。
 
third，The application of the new process is not the decline in cost but rising，But the effectiveness it brings is the improvement of environmental protection effects and product quality，Ruofu enzyme method 7-ACA、enzyme method amoxicillin, etc.，Many enterprises have changed the products after the product is changed，Cost increases while reducing the subsequent process and environmental pollution，It has to be reflected in the increase in the price of the drug drug。
 
It is worth noting that it is，China's raw medicine is the most criticized is overcapacity、Price stake sports betting appincrease Stake Sports Bettingfactors, etc.、Uniform pattern of area distribution、Price increase factors, etc.。Another，You need to pay attention to the implementation of the implementation of the new version of the basic drug directory to the industry opportunities for related raw materials:
 
First, the oral preparations in the basic medicine directory must take the lead in evaluation of the quality consistency of generic drugs，This requires new requirements for the quality of the raw materials，Related raw and auxiliary materials and packaging materials will also benefit from this;
 
Second, the proportion of new basic medicines in medical institutions at all levels、Perfect compensation mechanism, etc., will generate substantial benefits to the expansion of the base medicine，The demand for the corresponding raw materials has an extension function。